The Clorox Company $CLX Shares Sold by Pring Turner Capital Group Inc.

Pring Turner Capital Group Inc. reduced its position in The Clorox Company (NYSE:CLX) by 86.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 3,140 shares of the company’s stock after selling 19,751 shares during the quarter. Pring Turner Capital Group Inc.’s holdings in Clorox were worth $317,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Center for Financial Planning Inc. acquired a new position in shares of Clorox in the 3rd quarter valued at about $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in shares of Clorox in the 3rd quarter valued at about $25,000. Darwin Wealth Management LLC acquired a new position in shares of Clorox in the 2nd quarter valued at about $29,000. Ameriflex Group Inc. lifted its stake in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares in the last quarter. Finally, Vision Financial Markets LLC lifted its stake in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

CLX has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $91.00 price objective on shares of Clorox in a research note on Friday, May 1st. Wells Fargo & Company reduced their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. JPMorgan Chase & Co. reduced their price objective on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 target price on shares of Clorox in a report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus price target of $103.40.

Clorox Price Performance

CLX stock opened at $89.98 on Monday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The stock’s 50 day moving average is $98.46 and its two-hundred day moving average is $105.82. The company has a market capitalization of $10.88 billion, a PE ratio of 14.61, a P/E/G ratio of 0.47 and a beta of 0.56.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts predict that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.